Weekly digest · ISO week 25

Post-viral research digest, week 25 2026: 33 new studies

15 June 2026 – 21 June 2026 · published 21 June 2026 · Subscribe

  1. Research Tracker
  2. Weekly Digest
  3. Week 25 2026

Between 15 June 2026 and 21 June 2026 the tracker indexed 33 new peer-reviewed studies and 5 clinical-trial updates across 8 post-viral and post-infectious conditions.

By the numbers

33new studies this issue
5trial updates this issue
544studies currently in the feeds
620clinical trials tracked
546biomarkers catalogued

Studies tracked = entries across the 8 condition feeds (each feed keeps a rolling window of recent PubMed results); trials tracked = ClinicalTrials.gov records in the current trial snapshot (last run 2026-06-26); biomarkers catalogued = marker entries across all OSMF biomarker atlases.

In this issue:

New studies by condition

ME/CFS 8 new

Full feed: ME/CFS research tracker

Study on Sijunzi decoction regulating intestinal microbiota structure and metabolic profile for improving chronic fatigue syndrome.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 21 June 2026 · Shan, Yi, Jin, Jin, Wu, Yiduo, Yu, Runsheng et al. PubMed 42322758

Chronic fatigue syndrome (CFS) is a syndrome encompassing several systemic diseases. Sijunzi Decoction (SJZD) is a classic formula in traditional Chinese medicine (TCM) for the treatment of spleen deficiency syndrome.

Systems neuroendocrinology in ME/CFS and long COVID: a chronobiological framework for hormone-based research.

Frontiers in neuroendocrinology · 20 June 2026 · Thomas, Natalie, Huang, Katherine, Schneider-Futschik, Elena K, Pollack, Beth et al. PubMed 42320559

Hormonal dysregulation is increasingly reported in ME/CFS and Long COVID, yet the broader role of neuroendocrine disruption in these conditions remains underexplored. While changes in steroid, peptide, and neuropeptide hormones have been identified, these findings are often considered in isolation and without attention to their timing or integration within broader physiological systems.

Gastrointestinal symptoms correlate with core clinical features and systemic inflammation in myalgic encephalomyelitis/chronic fatigue syndrome.

Journal of translational medicine · 20 June 2026 · Brown, Mikayla, Vernon, Suzanne D, Indart, Alyssa C, Green, Peter H et al. PubMed 42321833

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem illness marked by fatigue, cognitive impairment, and post-exertional malaise. Gastrointestinal (GI) symptoms are frequently reported, yet their relationship to central features of the illness and biological correlates remains poorly understood.

[Not Available].

Der Nervenarzt · 18 June 2026 · Erbguth, F, Tegenthoff, M, Böwering-Möllenkamp, C, Schain, H et al. PubMed 42313182

No abstract available.

Effectiveness of adapted physical activity and therapeutic exercise programme in improving chronic fatigue syndrome in long COVID, delivered via hospital-based rehabilitation versus telerehabilitation.

Trials · 18 June 2026 · Kabir, Feroz, Yin, Khin Nyein, Jeffree, Mohammad Saffree, Ahmedy, Fatimah Binti et al. PubMed 42310705

Long COVID is a prevalent condition characterised by pain, fatigue, disability, and a multitude of health issues. There are various treatment options for managing long COVID symptoms, including non-pharmacological interventions like physiotherapy and rehabilitation, which can be effectively delivered either in institutional care settings or via telerehabilitation.

Self-management support needs for individuals with Myalgic Encephalomyelitis and their next of kin - a qualitative study.

BMC health services research · 16 June 2026 · Grønning, Kjersti, Lysfjord, Liv Eli, Røstad, Ann Katrin Hagen PubMed 42298601

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, disabling condition with limited evidence-based treatment options. Self-management support is recommended to improve people's coping and quality of life, yet little is known about whether the provided self-management support meet individuals with ME/CFS and their next of kins needs.

Fatigue-associated gut bacteria in Japanese healthy adults characterized by metagenomic analysis.

Scientific reports · 15 June 2026 · Masuoka, Hiroaki, Miyatake, Takumi, Park, Jonguk, Negishi, Hiroki et al. PubMed 42289444

Emerging evidence suggests that fatigue caused by accumulated stress may serve as a prodromal symptom of psychiatric disorders, and gut microbiome dysbiosis has been reported in many such conditions. However, little is known about microbial and metabolic signatures associated with fatigue in otherwise healthy individuals.

Gulf War Illness 1 new

Full feed: Gulf War Illness research tracker

Association between deployment and Gulf War Illness and adverse COVID outcomes in a nationwide cohort of 1990-1991 Gulf Era war veterans in the VA's Million Veteran Program.

PloS one · 15 June 2026 · White, Donna L, NonoDjotsa, Alice B S, Ahmed, Sarah T, Boyle, Stephen H et al. PubMed 42296096

U.S. military veterans deployed to the Persian Gulf to serve in the 1990-1991 Gulf War (GWVs) have expressed concerns about potential increased risk of experiencing adverse COVID-related health outcomes given broad near-unique exposure to multiple diverse toxic agents during deployment and ongoing ~30% prevalence of Gulf War Illness (GWI+), a chronic, medically unexplained multi-symptom disorder associated with...

Postural Orthostatic Tachycardia Syndrome (POTS) 6 new

Full feed: POTS research tracker

Robotic management of superior mesenteric artery syndrome after weight loss: a case report.

Journal of surgical case reports · 17 June 2026 · Kontogiannis, Cristina, Asif, Sami, Kharod, Amit PubMed 42305393

Superior mesenteric artery (SMA) syndrome is a rare cause of proximal intestinal obstruction resulting from compression of the third portion of the duodenum between the aorta and the SMA. It most commonly occurs in slender individuals or those experiencing rapid weight loss, but presentations can be atypical and diagnostically challenging.

Unusual presentation of scleroderma: case report.

AME case reports · 16 June 2026 · Finsterer, Josef PubMed 42299385

The combination of neurological, cardiac, and pulmonary disease in patients with systemic sclerosis (SS) is rare. The aim of the study was to report a patient with SS who manifested with migraine without aura, Raynaud's phenomenon, pulmonary hypertension, and postural tachycardia syndrome (POTS), a combination which has not been previously reported.

Hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome: patient experiences, disability and implications for rehabilitation.also MCAS

International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation · 16 June 2026 · Brandt, Lindsay, Kondratek, Melodie, Kim, Limmy, Ohanian, Hailey et al. PubMed 42298945

The diagnosis and management of hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome (HSD/hEDS) are a healthcare challenge because of the wide array of symptoms, lack of diagnostic biomarkers, and evolving management guidelines. This study aimed to describe patient experiences, disability, and self-perceived success managing HSD/hEDS, with or without comorbid postural orthostatic tachycardia...

Dysautonomia and Postural Orthostatic Tachycardia Syndrome (POTS) in the ENT Clinic: Differentiating Orthostatic Dizziness From Vestibular Migraine and Persistent Postural-Perceptual Dizziness (PPPD).

Cureus · 16 June 2026 · Zitser, Philip, Kolomiyets, Ilana, Imran, Maheen, Kulkarni, Aashi et al. PubMed 42299168

One of the most common complaints in ENT clinics is dizziness. Although most cases are caused by vestibular neuritis and benign paroxysmal positional vertigo (BPPV), a significant number of patients experience non-vestibular dizziness.

Mast Cell Activation Syndrome (MCAS) 16 new

Full feed: MCAS research tracker

Mast Cells and Cardiovascular Disorders.

Current vascular pharmacology · 19 June 2026 · Manolis, Antonis A, Manolis, Theodora A, Vouliotis, Apostolos, Manolis, Antonis S PubMed 42316564

Mastocytosis is a neoplasm characterised by clonal proliferation of mast cells (MCs) in the skin and other organs, including the heart, and symptoms produced by MC-derived mediators. MC activation syndrome (MCAS) relates to increased and inappropriate activation of MCs without clonal proliferation.

Ethnopharmacological investigation of Elaeocarpus sylvestris leaf extract in mitigating atopic dermatitis-like lesions via inflammatory signaling modulation.

Journal of ethnopharmacology · 19 June 2026 · Kim, So-Yeon, Do, Young-Ju, Lee, Su-Jung, Cho, Ye Eun et al. PubMed 42314808

Historically, Elaeocarpus sylvestris has served as a traditional medicinal agent for inflammatory disorders across East Asia. Recent studies have reported its antioxidant and anti-inflammatory activities, supporting its potential as a natural therapeutic resource for inflammatory skin diseases such as atopic dermatitis (AD).

Epithelial Duox2 Drives Chronic Colitis-Associated Fibrosis via the NLRP3-IL-33-Mast Cell Axis.

Combinatorial chemistry & high throughput screening · 19 June 2026 · Chen, Zhixiong, Yang, Juanmin, He, Zhigang PubMed 42316559

Intestinal fibrosis is a common and serious complication of chronic inflammatory bowel disease (IBD) associated with stricture and obstruction. Although oxidative stress has been associated with IBD, how Duox2, the major source of ROS in gut epithelium, promotes fibrosis remains unknown.

Association of the endosomal TLR4 pathway with dorsolateral prostatic remodeling induced by perinatal phthalate mixture exposure in rats.

Reproductive toxicology (Elmsford, N.Y.) · 19 June 2026 · Maria, Vinícius Luís Rocha da Silva, Santana, Ana Clara Pacheco de, Souza, Patrick Vieira, Rocha et al. PubMed 42315046

Phthalates are endocrine disruptors that alter the homeostasis of hormone-dependent organs. Perinatal exposure to endocrine disruptors can program different organs and promote morphological and metabolic alterations, increasing susceptibility to diseases later in life, as proposed by the Developmental Origins of Health and Disease (DOHaD) hypothesis.

Any role for respiratory allergens in IBS symptoms? From pathogenetic hypothesis to therapeutic implications.

Frontiers in allergy · 18 June 2026 · Rossi, Carlo Maria, Lenti, Marco Vincenzo, Di Sabatino, Antonio PubMed 42311633

Irritable bowel syndrome is a common disorder associated with substantial impairment in quality of life and remains challenging to manage due to its heterogeneous and incompletely understood pathophysiology leading to high rates of treatment failure. Recent evidence supports the existence of distinct IBS endotypes, including an emerging atopic variant characterised by allergic comorbidities, type 2 inflammation, and...

Rolling Up Transition Metal Chalcogenides/Oxide Heterostructures Enables Polarity-Tunable and High-Switchable Memristors.

Advanced materials (Deerfield Beach, Fla.) · 16 June 2026 · Wang, Xiaofan, Chen, Xiaokai, Qiao, Ruixi, Xu, Jing et al. PubMed 42299106

Harnessing transition metal dichalcogenides (TMDCs) for memristors provides a promising pathway toward high-density data storage and neuromorphic functionalities. Yet the single operation mode and insufficient on/off ratio extremely restrict the ultimate device performance.

Pathophysiology and emerging treatments for dermographic, cholinergic and cold urticaria.

Journal of the European Academy of Dermatology and Venereology : JEADV · 16 June 2026 · Bizjak-Suran, Mojca, Fležar, Matjaž, Pereira, Manuel Pedro PubMed 42299718

Chronic inducible urticarias (CIndUs), including symptomatic dermographism (SD), cholinergic urticaria (CholU) and cold urticaria (ColdU), are mast cell (MC)-driven conditions triggered by subtype-specific, definite and reproducible stimuli. Although often considered self-limiting, these diseases can persist for years and significantly impair quality of life.

Anaphylaxis during hemodialysis associated with a polysulfone membrane: evidence from basophil activation testing.

Kidney research and clinical practice · 16 June 2026 · Jung, Ji Yong, Moon, Da-Hye, Kim, Hyunsook, Chang, Jae Hyun et al. PubMed 42299450

Dialyzer-associated anaphylaxis is an uncommon but serious complication of hemodialysis. Although severe anaphylaxis is rare, milder hypersensitivity reactions are likely underrecognized and frequently misattributed to cardiopulmonary or volume-related causes.

Integrative machine learning and network toxicology framework for assessing environmental pollutant TCDD-induced osteoarthritis risk: a computational cheminformatics approach.

Frontiers in pharmacology · 15 June 2026 · Li, Lei, Zhang, Yihong, Qiu, Wenkui, Li, Xiaolong et al. PubMed 42292825

Osteoarthritis (OA) is a prevalent degenerative joint disease influenced by both genetic susceptibility and environmental factors. Increasing evidence suggests that exposure to persistent environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), may contribute to OA progression; however, the molecular mechanisms underlying these effects remain unclear.

Characterization of a mouse model to study mechanisms of hemophilia A pain.

Blood advances · 15 June 2026 · Fouda, Raghda T, Argueta, Donovan Alexander, Goel, Yugal, Velasco, Graham J et al. PubMed 42295153

Pain is a debilitating feature of hemophilia A (HA), yet it remains understudied. We developed models of chronic and acute pain in factor VIII knock-out (FVIIIKO; B6;129S-FVIIItm1Kaz/J), demonstrating characteristic features of hemarthrosis pain and gait.

Other post-viral and post-infectious syndromes 2 new

Full feed: Other post-viral research tracker

Photodistributed RIME Syndrome Treated With Etanercept.

Pediatric dermatology · 15 June 2026 · Javaheri, Elika D, Harb, Dana, Damon, Amanda, Borch-Christensen, Bo et al. PubMed 42289385

Reactive infectious mucocutaneous eruption (RIME) is a post-infectious mucositis which primarily affects pediatric patients. We report a 14-year-old girl with recent intensive sun exposure who developed RIME in a photodistributed pattern.

No new studies this window for: Long COVID, PACVS, Lyme / PTLDS.

Trial activity

ClinicalTrials.gov records whose registry entry was last updated between 15 June 2026 and 21 June 2026. A registry update can be anything from a status change to an edited contact field; status shown is as of the tracker snapshot.

NCTTrialStatusPhaseAgentsUpdated
NCT06974084A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Long COVID
Not Yet RecruitingPhase 2Maraviroc, Atorvastatin, 10Mg, 20Mg, 40Mg2026-06-18
NCT06142253Water-based Activity to Enhance Recovery in Long COVID-19
Long COVID
RecruitingNot applicableWater+Ct2026-06-18
NCT06593600Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
POTS, Other post-viral
Active Not RecruitingPhase 2Regn75442026-06-17
NCT05967052Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
ME/CFS
TerminatedPhase 2Pregabalin, Independent Walking Training, Gradual Movement Therapy In The Ward2026-06-17
NCT07651371Effects of a Physical Rehabilitation Program on Long COVID
Long COVID
CompletedNot applicablePhysical Rehabilitation, Treadmill Ergometer, Pulley2026-06-16

Browse all tracked trials: clinical trials tracker.

Get the digest every week

The same issue goes out by email on Substack. RSS and JSON Feed are available for readers and aggregators.

Subscribe on SubstackRSS feedJSON Feed

Cite this issue

Open Source Medicine Foundation. Post-viral research digest, week 25 2026: 33 new studies. Published 21 June 2026. https://research.opensourcemed.info/digest/2026-W25.html

Issues are regenerated from the live tracker data within their week and frozen afterwards; the snapshot behind this page is at data/2026-W25.json.

Disclaimer. This digest is an automated, unreviewed listing of newly indexed PubMed records and ClinicalTrials.gov registry updates compiled by the Open Source Medicine Foundation. Inclusion is not endorsement; abstracts are excerpted verbatim from PubMed and may contain errors. It is not medical advice. Discuss any treatment decision with a qualified clinician.